|
Nasdaq Bed Bath & Beyond Inc., down $12.50 at $61.17 The home goods retailer posted a weak earnings outlook saying it had to issue more coupons to get more people shopping. Onyx Pharmaceuticals Inc., up $19.20 at $63.78 A Food and Drug Administration panel recommended approval of the drug developer's treatment for people with advanced blood cancer. Celgene Corp., down $7.72 at $59.45 The biopharmaceutical company said it slowed its plans to gain additional marketing approval for its cancer drug Revlimid.
Copyright 2012 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries
Community |
Perspectives
|
Law & Courts |
Leisure Time
|
Spiritual Life |
Health & Fitness |
Teen Scene
Calendar
|
Letters to the Editor